Europe agrees to sell its first artificial core
The shares of the medical technology company "Carmat" recorded their biggest gains in more than seven years after the company obtained approval to sell the first-ever total artificial heart in Europe, the culmination of efforts that lasted 27 years.
According to Bloomberg News, Carmat obtained the approval of European regulators to sell it and give it the CE mark, which means that it can be transported within the countries of the European Common Market without hindrance, as the organizers saw that it might be a successful way to save patients who suffer Of untreated heart problems.
As a result, the shares of the French company rose by 50 percent, the biggest gain since May 2013.
Stephane Piatt, CEO of Carmat, said yesterday (Thursday) in an interview with BFM Business that “ It took 10 years to obtain the approval of European authorities, which is a record. ”
"We will have to work with doctors and medical centers now to provide them with the device, and we will have to search for patients who need it," he added.
The production stage will be accurate ».
The surgeon and inventor of heart valves, Alain Carpentier, proposed the development of an artificial heart to the French businessman and founder of the "Matra" missile company, Jean-Luc Lagardier, in 1993.
Lagardier placed a number of Matra's laboratories and engineers at Carpentier's disposal to start the project that expanded. Over the years, it resulted in the establishment of the Carmat Company.